Table 3.
Metabolic syndrome components, definition, and cardiovascular risk factors in men with a normal body mass index by body fat tertiles
| Variable (N = 3042) | BF <18.65% (N = 1011) | BF >18.65–23.15% (N = 1014) | BF >23.15% (N = 1017) | Age+race Padj-value for trend |
|---|---|---|---|---|
| Metabolic syndrome | N (%) | N (%) | N (%) | |
| Central obesity ATP (WC >102 cm) | 2 (0.18) | 4 (0.43) | 23 (1.95)‡ | 0.0004 |
| Central obesity by (W/H≥0.90) waist-to-hip ratio | 270 (26.71) | 347 (34.30) | 396 (39.01)† | <0.0001 |
| High triglycerides (>1.7 mmol/L) or lipid treatment | 116 (11.95) | 193 (21.02)† | 283 (31.12)* | <0.0001 |
| Low high-density lipoprotein (<1.04 mmol/L) | 149 (18.10) | 181 (21.25) | 225 (27.20)* | <0.0001 |
| High blood pressure (>130/>85 mmHg) or treatment for hypertension | 319 (26.54) | 353 (33.45) | 484 (46.84)‡ | 0.0042 |
| High fasting plasma glucosea (>5.55 mmol/L) or previously diagnosed diabetes | 169 (16.58) | 220 (21.51) | 293 (28.62)‡ | 0.0044 |
| Metabolic syndrome by ATP III criteriaa | 44 (5.28) | 75 (8.34) | 143 (15.83)* | <0.0001 |
| Cardiovascular risk factors | ||||
| Dyslipidaemia | 93 (10.62) | 136 (16.05)§ | 189 (20.44)* | <0.0001 |
| Hypertension | 212 (14.86) | 226 (19.68)§ | 342 (31.70)‖ | 0.039 |
| Diabetes | 40 (2.26) | 40 (2.07) | 50 (2.59) | 0.30 |
| Ever smokers | 561 (57.00) | 589 (59.67) | 648 (63.27) | 0.92 |
| CVD (myocardial infarction+stroke) | 46 (3.46) | 63 (4.82) | 69 (4.35) | 0.67 |
P-values adjusted for age and race.
aFasting morning samples.
*P-value = <0.0001 when compared with BF <18.65%.
†P-value <0.001 when compared with BF <18.65%.
‡P-value <0.01 when compared with BF <18.65%.
§P-value <0.05 when compared with BF <18.65%.
‖P-value <0.07 when compared with BF <18.65%.